News & Articles

Guest editorial features key takeaways from Balancing the Future Podcast, season 2, episode 11, by METTLER TOLEDO

Discover how the HeadSMART II study is combining blood biomarkers, digital neurocognitive testing and AI to identify patients at risk of persistent TBI symptoms

ECO rack GRIPTIPS® pipette tips are now translucent, making the recycled material more suitable for a wider range of new products

An analysis of data from more than 33,000 women found that breast density could partially explain the link between a higher body weight at age 20 and a lower chance of post-menopausal breast cancer

Dr. Vasiliki E. Kalodimou on women in STEM, global collaboration, and the next era of regenerative medicine

New Ancora assays for oncology produce precision results with MRD-grade sensitivity, delivering the full biological picture for every sample

The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics (CDx) and laboratory infrastructure, supporting active programs with leading pharma partners

Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people

Take the survey and submit a guest editorial

Authentic voices. Shared expertise. A global conversation advancing the future of diagnostics.

New portfolio aims to support biosimilar developers accelerate the path to analytical similarity and improve process economics

Q&A with Microbiology in Health and Disease Lead Editor Liang Wang at the Journal of Applied Microbiology

Join the global clinical diagnostics conversation on LinkedIn

Guest editorial written by Aida Noor, Biomedical Scientist, Founder of Biomedical Science & Beyond, CLINICAL24 Ambassador

Guest editorial by Maya Carlyle, Principal AI Engineer at the National Physical Laboratory (NPL)

Guest editorial by Frank Sandulu, award-winning Biomedical Scientist and CEO, Biomed Connect

Guest Editorial by Stephanie Ibbotson, Senior Director, Strategic Marketing and Market Access, Diasorin

Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them

A new bench-top bioreactor platform with process control designed to support GMP-ready environments from 100 mL to 10 L working volume

Yale Professor Joe El-Khoury discusses Aletta, the ADOPT study and how autonomous blood collection could improve standardization, capacity, and quality across laboratory medicine

Irena Ivanova explores the potential of artificial intelligence to strengthen laboratory quality, efficiency and access to care while preserving human oversight and compassion

A validated bioassay that worked yesterday is not guaranteed to work tomorrow, and CRO Prolytix is urging the industry to rethink what ‘validated’ really means

Guest editorial by Russ Lebovitz, MD, PhD, is CEO and Co-Founder of Amprion

As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions